The Option
The Option
Jason Dibelius
Episode 269 - Dr Tommy Rhee
1 hour 30 minutes Posted Jan 16, 2026 at 12:00 am.
What got him into the chiropractic and sports medicine profession, military service and how it set a standard on how he wanted to succeed.
How good conversations can inspire people who fell off, as well as the ones who seek purpose, learning from mistakes, and the self-correction
Stem Cells vs "RheeGen: the compare and contrast analysis, and why the latter is beneficial, also, discussing preventative measures, residual treatment, and reversing ailments and complications, the future of regenerative medicine, The power of the second opinion
Symptoms, and how to treat them, giving the patient permission to tell you what is wrong without understanding terminology, how the preventive, the treatment and the cure are connected
The inciting incidents that make people care about their health
Are there moments of doubt where something works or not, or it that diminished with "checking all the boxes?" Plus, nutrition and the lack of emphasis on the research
preventive maintenance for juniors, and how to develop properly
Let's have a little fun: good books, good movies, movie characters without superpowers who are still heroes, book promo etc., escapisms that allows you to function in your career
we got caught up in military stories
0:00
1:30:20
Download MP3
Show notes
Dr. Thomas Rhee is an American leading Chiropractor with a concentration in regenerative medicine. With an impressive background that spans UCLA, the Tampa Bay Buccaneers, and international recognition in sports health, Dr. Tommy Rhee is no stranger to cutting-edge healing techniques. He has dedicated over three years to the development of "RheeGen®." Recognizing the limitations and risks of injection-based stem cell therapies, he envisioned a safer, more accessible alternative — one that could deliver the healing power of regenerative medicine without using live cells or invasive procedures. He is also the author of "The Future of Regenerative Medicine: Unlocking the Potential of Topical Stem Cell Therapy."